Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Centessa Pharmaceuticals has raised $250.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2025.
Centessa Pharmaceuticals's investors include Franklin Templeton, General Atlantic, Wellington Management, Samsara BioCapital, Janus Henderson Investors.
Centessa Pharmaceuticals is headquartered in Cambridge, United States.
Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.
Centessa Pharmaceuticals is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Centessa Pharmaceuticals — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/centessa-pharmaceuticals. Accessed September 14, 2026.
VCBacked. (2025). Centessa Pharmaceuticals — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/centessa-pharmaceuticals
{{cite web |title=Centessa Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/centessa-pharmaceuticals |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated